Evidence map›Paper›PMID 29183553›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2017

Childhood multidrug-resistant tuberculosis in the European Union and European Economic Area: an analysis of tuberculosis surveillance data from 2007 to 2015.

Csaba Ködmön, Martin van den Boom, Phillip Zucs, Marieke Johanna van der Werf

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Csaba KödmönEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Martin van den BoomJoint Tuberculosis, HIV and Viral Hepatitis Programme, World Health Organization, Regional Office for Europe, Copenhagen, Denmark.
Phillip ZucsEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Marieke Johanna van der WerfEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.

Funding

World Health Organization 001
6 · The paper itself

Abstract

BackgroundConfirming tuberculosis (TB) in children and obtaining information on drug susceptibility is essential to ensure adequate treatment. We assessed whether there are gaps in diagnosis and treatment of multidrug-resistant (MDR) TB in children in the European Union and European Economic Area (EU/EEA), quantified the burden of MDR TB in children and characterised cases.

Indexed as

European UnionAdolescentAntitubercular AgentsChildChild, PreschoolEuropeFemaleHumansInfantInfant, NewbornMaleMycobacterium tuberculosisOutcome Assessment, Health CarePopulation SurveillanceTuberculosis, Multidrug-ResistantAntitubercular AgentsEuropean Unionextrapulmonary tuberculosismultidrug resistancepaediatric tuberculosistuberculosis

Identifiers

PMID29183553
PMCPMC5710661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.